mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.05 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.05 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.06 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.06 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.06 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.087 |
0.06 |